Commentary: Position statement on augmented intelligence (AuI) - 12/09/19
Doi : 10.1016/j.jaad.2019.06.032
Carrie Kovarik, MD a, ⁎ 
, Ivy Lee, MD b, Justin Ko, MD c
on behalf of
, Ivy Lee, MD b, Justin Ko, MD con behalf of
Ad Hoc Task Force on Augmented Intelligence
Adewole Adamson, MD, Clark Otley, MD, Joseph Kvedar, MD, Priyank Vedak, MD, Susan Huang, MD, Matthew Fitzgerald, DrPH, Rachna Chaudhari, MPH
a Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
b Pasadena Premier Dermatology, Pasadena, California
c Department of Dermatology, Stanford University, Stanford, California
∗Reprint requests: Carrie Kovarik, MD, Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, 3600 Spruce St, 2 Maloney Building, Philadelphia, PA 19104.Department of DermatologyPerelman School of MedicineUniversity of Pennsylvania3600 Spruce St, 2 Maloney BuildingPhiladelphiaPA19104
| Additional task force members include Adewole Adamson, MD, Clark Otley, MD, Joseph Kvedar, MD, Priyank Vedak, MD, Susan Huang, MD, Matthew Fitzgerald, DrPH, and Rachna Chaudhari, MPH. |
|
| Funding sources: None. |
|
| Conflicts of interest: This task force has been put together by the American Academy of Dermatology, but the members have not been paid to participate. There are no conflicts of interest. |
© 2019
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 81 - N° 4
P. 998-1000 - octobre 2019 Retour au numéro
Article précédent
- Cutaneous angioimmunoblastic T-cell lymphoma: Epstein-Barr virus positivity and its effects on clinicopathologic features
- Woo Jin Lee, Kwang Hee Won, Jae Won Choi, Chong Hyun Won, Sung Eun Chang, Jee Ho Choi, Mi Woo Lee
- Dermatologic manifestations associated with electronic cigarette use
- Michael J. Visconti, Kurt A. Ashack
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?